SCHEMBL24252013

SCHEMBL24252013

CCCCCC(C)(CCCC)C1CC(F)(F)C1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.32
LPAR1 Q92633 1/20 0.32
LPAR3 Q9UBY5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21884189 0.98 CES2 (0.35) CES2LPAR1LPAR3
SCHEMBL21470295 0.98 CES2 (0.33) CES2LPAR1LPAR3
SCHEMBL19628911 0.96 CES2 (0.36) CES2LPAR1LPAR3
SCHEMBL19879718 0.93 CES2 (0.34) CES2LPAR1LPAR3
SCHEMBL19731420 0.89 CES2 (0.31) CES2LPAR1LPAR3
SCHEMBL22624049 0.89
SCHEMBL22624147 0.82
SCHEMBL22623884 0.80
SCHEMBL22624022 0.77 CES2 (0.32) CES2LPAR1LPAR3
SCHEMBL21191697 0.76 CES2 (0.38) CES2LPAR1LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof MAPK11, WEE1, NOS1 CES2 4408/4885LPAR1 4032/4885LPAR3 4383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.